GB9818756D0 - Superoxide dismutase as a vaccine antigen - Google Patents

Superoxide dismutase as a vaccine antigen

Info

Publication number
GB9818756D0
GB9818756D0 GBGB9818756.0A GB9818756A GB9818756D0 GB 9818756 D0 GB9818756 D0 GB 9818756D0 GB 9818756 A GB9818756 A GB 9818756A GB 9818756 D0 GB9818756 D0 GB 9818756D0
Authority
GB
United Kingdom
Prior art keywords
superoxide dismutase
vaccine antigen
vaccine
antigen
dismutase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9818756.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMP COLLEGE SCHOOL OF MEDICINE
MICROBIOLOGICAL RESEARCH AGENC
Original Assignee
IMP COLLEGE SCHOOL OF MEDICINE
MICROBIOLOGICAL RESEARCH AGENC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMP COLLEGE SCHOOL OF MEDICINE, MICROBIOLOGICAL RESEARCH AGENC filed Critical IMP COLLEGE SCHOOL OF MEDICINE
Priority to GBGB9818756.0A priority Critical patent/GB9818756D0/en
Publication of GB9818756D0 publication Critical patent/GB9818756D0/en
Priority to CA002341639A priority patent/CA2341639A1/en
Priority to AU56350/99A priority patent/AU761394B2/en
Priority to JP2000567704A priority patent/JP2002523521A/en
Priority to PCT/GB1999/002828 priority patent/WO2000012718A1/en
Priority to EP99943065A priority patent/EP1108038A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9818756.0A 1998-08-27 1998-08-27 Superoxide dismutase as a vaccine antigen Ceased GB9818756D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9818756.0A GB9818756D0 (en) 1998-08-27 1998-08-27 Superoxide dismutase as a vaccine antigen
CA002341639A CA2341639A1 (en) 1998-08-27 1999-08-27 Superoxide dismutase as a vaccine antigen
AU56350/99A AU761394B2 (en) 1998-08-27 1999-08-27 Superoxide dismutase as a vaccine antigen
JP2000567704A JP2002523521A (en) 1998-08-27 1999-08-27 Superoxide dismutase as a vaccine antigen
PCT/GB1999/002828 WO2000012718A1 (en) 1998-08-27 1999-08-27 Superoxide dismutase as a vaccine antigen
EP99943065A EP1108038A1 (en) 1998-08-27 1999-08-27 Superoxide dismutase as a vaccine antigen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9818756.0A GB9818756D0 (en) 1998-08-27 1998-08-27 Superoxide dismutase as a vaccine antigen

Publications (1)

Publication Number Publication Date
GB9818756D0 true GB9818756D0 (en) 1998-10-21

Family

ID=10837964

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9818756.0A Ceased GB9818756D0 (en) 1998-08-27 1998-08-27 Superoxide dismutase as a vaccine antigen

Country Status (6)

Country Link
EP (1) EP1108038A1 (en)
JP (1) JP2002523521A (en)
AU (1) AU761394B2 (en)
CA (1) CA2341639A1 (en)
GB (1) GB9818756D0 (en)
WO (1) WO2000012718A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4668191B2 (en) 2003-08-20 2011-04-13 アモールフィックス・ライフ・サイエンシィズ・リミテッド Epitope protection assay and method for detecting protein conformation
US7794692B2 (en) 2005-12-02 2010-09-14 Amorfix Life Sciences Ltd. Methods and compositions for detecting amyotrophic lateral sclerosis
US7887803B2 (en) 2005-12-02 2011-02-15 Amorfix Life Sciences Methods and compositions to treat misfolded-SOD1 mediated diseases
WO2007098607A1 (en) 2006-03-03 2007-09-07 Amorfix Life Sciences Ltd. Methods and compositions to treat and detect misfolded-sod1 mediated diseases
CN108794584B (en) * 2018-06-13 2021-02-19 华中师范大学 Actinobacillus pleuropneumoniae immunoprotective antigen protein APJL _1380 and application thereof
CN108840913B (en) * 2018-06-13 2020-11-06 华中师范大学 Actinobacillus pleuropneumoniae immunoprotective antigen protein APJL _0922 and application thereof
CN108822192B (en) * 2018-06-13 2020-11-06 华中师范大学 Actinobacillus pleuropneumoniae immunoprotective antigen protein APJL _1976 and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0474134A (en) * 1990-07-13 1992-03-09 Fujisawa Pharmaceut Co Ltd Subcutaneously injecting preparation for prevention and therapy of nephrosis syndrome and nephritis
DE4038563A1 (en) * 1990-12-04 1992-06-11 Gruenenthal Gmbh USE OF SUPEROXIDE DISMUTASES FOR PROPHYLAXIS AND / OR TREATMENT OF ORGAN FAILURE IN RISK PATIENTS WITH POLYTRAUMA
JPH04327541A (en) * 1991-04-23 1992-11-17 Nippon Kayaku Co Ltd Agent for treating damage of implanted organ caused by rejection thereof
FR2675997B1 (en) * 1991-05-03 1993-12-24 Oreal TOPICAL ANTI FREE RADICAL COMPOSITION BASED ON SUPEROXIDE DISMUTASE AND A PHOSPHONIC DERIVATIVE.

Also Published As

Publication number Publication date
AU761394B2 (en) 2003-06-05
AU5635099A (en) 2000-03-21
CA2341639A1 (en) 2000-03-09
EP1108038A1 (en) 2001-06-20
WO2000012718A1 (en) 2000-03-09
JP2002523521A (en) 2002-07-30

Similar Documents

Publication Publication Date Title
IL145045A0 (en) Vaccine
HUP0202885A3 (en) Vaccines
PL341761A1 (en) Vaccine
GB9711990D0 (en) Vaccine
GB9726555D0 (en) Vaccine
IL188686A0 (en) Vaccine
GB0119275D0 (en) Safety Cover
GB9812613D0 (en) Vaccine
AU141931S (en) Packaging
HUP0105392A3 (en) Enhanced vaccines
GB2350352B (en) Packaging
GB9818756D0 (en) Superoxide dismutase as a vaccine antigen
GB0027072D0 (en) Vaccine
GB9906437D0 (en) Vaccine
GB9917058D0 (en) Packaging
GB9915419D0 (en) Antigens
GB2346602B (en) Packaging
GB0128848D0 (en) Packaging case
GB9911988D0 (en) Packaging means
GB9917163D0 (en) Packaging
GB9910029D0 (en) Packaging
GB9905881D0 (en) Packaging
HUP0203512A3 (en) Packaging
GB9909072D0 (en) Vaccine
GB9820956D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)